ClinicalTrials.Veeva

Menu

Cervical Lidocaine for Intrauterine Device Insertion Pain (CLIIP)

The Washington University logo

The Washington University

Status

Completed

Conditions

Pain

Treatments

Drug: Water based lubricant
Drug: 2% lidocaine gel

Study type

Interventional

Funder types

Other

Identifiers

NCT01411995
201105067

Details and patient eligibility

About

The aim of this study is to evaluate intracervical lidocaine gel as a means to decrease pain associated with intrauterine device (IUD) insertion. They will be randomized to either placebo (inert water based lubricating gel) or 2% lidocaine gel to be placed intracervically via angio-catheter just before intrauterine device insertion. Anticipated pain scores will be assessed using a visual analog scale prior to insertion. Using the same pain scale, patients will again be asked at the end of the procedure to rate their pain.

Full description

Double blind randomized controlled trial.

Primary outcome: Pain reported on Visual Analog Scale (VAS) Intervention: 2% lidocaine gel at the tenaculum site and intracervical prior to intrauterine device placement

Enrollment

200 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 18-45 yrs
  • selecting intrauterine device contraception
  • able and willing to consent

Exclusion criteria

  • non-English speaking
  • current intrauterine device use
  • expulsion of intrauterine device within 2 weeks
  • allergy to lidocaine or water based lubricant

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

200 participants in 2 patient groups, including a placebo group

2% Lidocaine gel
Experimental group
Description:
Women randomized to the Lidocaine arm will receive a total of 3-5cc of 2% gel at the tenaculum site and within the endocervical canal
Treatment:
Drug: 2% lidocaine gel
Water based lubricant
Placebo Comparator group
Description:
Women randomized to the placebo arm will receive a total of 3-5cc of water based lubricant at the tenaculum site and within the the endocervical canal
Treatment:
Drug: Water based lubricant

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems